COVID

Even after more than two years of a global pandemic, we still don’t know much about COVID-19 as a novel virus.

However, there appears to be some good news for parents of children and young adults.

According to a new scientific statementTrusted Source from the American Heart Association, heart complications caused by COVID-19 are rare and mostly treatable (AHA).

“It’s fantastic that the AHA is emphasising the paediatric population with their scientific statement,” said Dr. Simon Lee, a paediatric cardiologist at Nationwide Children’s Hospital in Columbus, Ohio. “We must continue to emphasise the importance of research into the short- and long-term cardiovascular effects of COVID-19.”

Following COVID-19 infection, for example, some children developed a new multi-system inflammatory syndrome (MIS-C), which causes inflammation in vital organs such as the heart and lungs.

MIS-C is a serious concern, but it is also uncommon.

Symptoms of Covid-19: The list is getting longer, and some symptoms are  longer-term - Vox

According to the AHA researchers, one out of every 3,164 children infected with SARS-CoV-2 developed MIS-C in the first year of the pandemic. The overall risk of MIS-C-related long-term complications and death was less than 2%.

The majority of children recovered from this disorder within one to four weeks of being diagnosed.

That’s encouraging, but we shouldn’t dismiss the issue entirely, according to Dr. Allan Greissman, a paediatric intensivist at Pediatric Critical Care of South Florida.

“In the long run, we’ll have to study these children longitudinally with serial MRIs to look at their heart and the amount of scarring, fibrosis, or even decreased function that can be seen on the cardiac MRI,” Greissman told Healthline.

He also stated that MIS-C cases appeared to be decreasing.

“With the delta virus, the amount of MIS-C we were seeing in relation to heart disease appeared to increase, but not so much with the omicron virus,” he explained. “The Omicron variant resulted in very little, if any, MIS-C disease.” We haven’t seen a child with MIS-C-related heart disease in our facility in at least two months.”

One possible explanation is that more children are now eligible for COVID-19 vaccines. According to research, the Pfizer COVID-19 vaccine could reduce the risk of MIS-C in children by up to 91 percent.

Leave a Reply

Your email address will not be published. Required fields are marked *

Sign Up for Our Newsletters

Get Notified For Latest Updates And Exclusive Offers As Well

You May Also Like

The Tomato Flu Outbreak Has Now Spread To Two More Indian States.

According To The Findings Of A Study That Was Published In “The Lancet Respiratory Medicine,” The Disease Has Surfaced In The Indian State Of Kerala In Children Who Are Younger Than Five Years Old.

Risk Factors In Staphylococcus Isolated From Pets Living With A Patient With Methicillin-Resistant Staphylococcus Aureus Infection

Pets may play an important role in the survival of methicillin-resistant (MR)…

Fuel Your Brain: The Best and Worst Foods for Optimal Mental Health

Enhance Memory, Concentration, and Brain Function with These Foods

A Respiratory Virus Kills 100,000 Infants Under The Age Of Five.

While COVID-19 and monkeypox take center stage, recent research reveals the terrible…